Core Viewpoint - Healthcare stocks are considered recession-resistant and can be attractive for dividend investors, but caution is needed due to potential yield and value traps [1] Group 1: High-Yield Healthcare Stocks - Among U.S.-listed healthcare stocks with market caps of at least $200 million, the three highest-yielding stocks are Perrigo, Pfizer, and Embecta [2] Group 2: Perrigo Analysis - Perrigo has seen a significant decline in its stock price, dropping by 90% over the past decade and 41% in the last year due to declining sales, weak guidance, and analyst downgrades [3][4] - The current forward dividend yield for Perrigo is 8.2%, with a dividend payout ratio of 41.6% and a 23-year track record of dividend growth, trading at less than 6 times forward earnings [5] - Despite the high yield, Perrigo may be a value trap until positive news emerges [5] Group 3: Pfizer Analysis - Pfizer's stock has become a high-yield dividend stock following a decline in revenue and earnings post-pandemic, with a current forward dividend yield of 6.7% [6] - Unlike Perrigo, Pfizer shows signs of potential recovery, with strong growth in non-COVID blockbuster drugs and an upcoming GLP-1 product launch that could act as a catalyst for improved results and valuation expansion [7][8]